Literature DB >> 8943489

"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis.

G Moroni1, S Quaglini, M Maccario, G Banfi, C Ponticelli.   

Abstract

We retrospectively analyzed the courses of 70 patients with lupus nephritis followed for 5 to 30 years (median 127 months). Patients survival was 100% at 10 years and 86% at 20 years. The probability of not reaching the end point (persistent doubling of plasma creatinine) was 85% at 10 years and 72% at 20 years. A multivariate analysis of variables at presentation showed that male sex (P = 0.005) and hematocrit lower than 36% (P = 0.01) were associated with the end point (relative risk 7.5 and 14). We then analyzed for the role of renal flare-ups, defined either as a rapid increase in plasma creatinine or by an increase in proteinuria. Patients with renal flares of any type had more probabilities of reaching the end point than patients who never had flares (P = 0.03; relative risk 6.8). The hazard of the end point was 27 times higher in patients with flares along with rapid increased in plasma creatinine than in patients without flares or with flares with proteinuria alone (P < 0.00001). This hazard was higher when plasma creatinine did not return to the basal levels within two months after treatment (P < 0.00001).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943489     DOI: 10.1038/ki.1996.528

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  51 in total

Review 1.  Treatment of severe proliferative lupus nephritis: the current state.

Authors:  C C Mok; R W S Wong; K N Lai
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

2.  Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center.

Authors:  M Funauchi; H Shimadzu; C Tamaki; T Yamagata; Y Nozaki; M Sugiyama; S Ikoma; K Kinoshita
Journal:  Rheumatol Int       Date:  2006-08-31       Impact factor: 2.631

3.  Is serum uric acid a predictor of long-term renal outcome in lupus nephritis?

Authors:  Michelle Remião Ugolini-Lopes; Samara S Gavinier; Elaine Leon; Vilma Trindade Viana; Eduardo Ferreira Borba; Eloisa Bonfá
Journal:  Clin Rheumatol       Date:  2019-06-02       Impact factor: 2.980

4.  Long-term outcome of patients with lupus nephritis: a single center experience.

Authors:  Senija Rasić; Amira Srna; Snezana Uncanin; Jasminka Dzemidzić; Damir Rebić; Alma Muslimović; Maida Rakanović-Todić; Aida Hamzić-Mehmedbasić
Journal:  Bosn J Basic Med Sci       Date:  2010-04       Impact factor: 3.363

5.  Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications.

Authors:  Daniel J Birmingham; Brad H Rovin; Ganesh Shidham; Michael Bissell; Haikady N Nagaraja; Lee A Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-01       Impact factor: 8.237

6.  Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up.

Authors:  Lorenza Maria Argolini; Giulia Frontini; Elena Elefante; Francesca Saccon; Valentina Binda; Chiara Tani; Isabella Scotti; Linda Carli; Mariele Gatto; Ciro Esposito; Maria Gerosa; Roberto Caporali; Andrea Doria; Piergiorgio Messa; Marta Mosca; Gabriella Moroni
Journal:  J Nephrol       Date:  2020-05-27       Impact factor: 3.902

7.  Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers.

Authors:  Paula Budu-Grajdeanu; Richard C Schugart; Avner Friedman; Daniel J Birmingham; Brad H Rovin
Journal:  Theor Biol Med Model       Date:  2010-05-17       Impact factor: 2.432

8.  New and emerging treatment approaches to lupus.

Authors:  Marion Haubitz
Journal:  Biologics       Date:  2010-09-13

9.  [Lupusnephritis].

Authors:  M Haubitz
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

10.  Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus.

Authors:  Zhenpeng Dai; Cameron J Turtle; Garrett C Booth; Stanley R Riddell; Theodore A Gooley; Anne M Stevens; Thomas Spies; Veronika Groh
Journal:  J Exp Med       Date:  2009-03-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.